WHO recommends antibody treatment for some COVID-19 patients
The World Health Organization has recommended that an antibody treatment be used for some COVID-19 patients in an update to its coronavirus treatment guidelines.
The recommendation, issued on Friday and based off of experimental trials, encourages the two antibodies produced by Regeneron — casirivimab and imdevimab — be used on COVID-19 patients “who are non-severe and at higher risk for hospitalization.”
In the United States, the antibody treatment is recommended for use on patients with mild-to-moderate coronavirus cases to prevent a need for hospitalization.
Due to the treatment’s high cost and limited availability, the WHO is negotiating with companies and working with humanitarian organizations to ensure it is produced at lower costs and becomes available to all in need, including in low- and middle-income countries where access to the treatment is difficult. ...
